Banner
HomeLast Word → Sure, cancer mutates, but it has other ways to resist treatment

Sure, cancer mutates, but it has other ways to resist treatment Print E-mail
Written by Fabian V. Filipp | The Conversation   
Tuesday, 10 April 2018 16:35

Because of advances in drug design and precision medicine, researchers have been able to target certain molecules within a cell at the root of a particular disease and to develop specific therapies to undo their damages. Today, precision targeting combines therapy decisions with molecular insights to offer hope after a life-changing cancer diagnosis.

But there's a dark side to cancer-killing drugs designed to match distinct cancer mutations like a key into a lock. Some cancers that initially respond to targeted chemotherapy become treatment-resistant - and the drug itself may not be the culprit.

New research helps explain how therapy-resistant cancers arise, findings with important implications for the future of cancer therapy. It shows how hidden, subtle layers of regulation - epigenetics - control the activity of genes to produce drug-resistant surviving cells.

Read More

Last Updated on Thursday, 10 May 2018 09:36
 


Banner
Website design, development, and hosting provided by
Netphiles